サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1437516

ヒドロキシジン市場：剤形別、適応症別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Hydroxyzine Market, By Dosage Form, By Indication Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 289 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
ヒドロキシジン市場：剤形別、適応症別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年02月20日
発行: AnalystView Market Insights
ページ情報: 英文 289 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ヒドロキシジンの市場規模は2023年に2億1,330万米ドルとなり、2024年から2032年にかけてCAGR 5.5%で拡大

ヒドロキシジン市場-市場力学

アレルギー有病率の上昇が市場成長を牽引

過去数十年にわたり、世界中でアレルギーおよび関連疾患の頻度が増加しています。アレルギー反応を経験する人の数は、いくつかの理由で増加しています。その一例として、2022年4月に最終更新されたAllergy Facts and Figuresによると、米国ではアレルギーが慢性疾患の6番目に多い原因となっており、毎年約5,000万人が罹患しています。その結果、米国ではアレルギーの有病率が高く、治療法の改善が必要とされています。この点に関して、2021年11月にIJERPHに発表された論文では、アレルギーの正確な原因は不明であるにもかかわらず、遺伝的および環境的要因がアレルギー疾患の世界的負担に大きく寄与していると述べられています。さらに、いくつかの研究によれば、ヒドロキシジンはアレルギーに関連したかゆみを和らげるために利用される可能性があります。ヒドロキシジンは抗ヒスタミン薬であり、アレルギー反応が起こったときにヒスタミンとして知られる特定の有機化合物が体内で産生されるのを防ぐことによって機能します。したがって、病気の負担をコントロールするためにヒドロキシジンの必要性が高まっています。その結果、対象人口のアレルギー負荷が大きく、アレルギーに対するヒドロキシジンの治療上の利点が市場拡大の原動力になると予想されます。

ヒドロキシジン市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約5.5％のCAGRで毎年成長すると予測されています。

剤形セグメンテーションでは、錠剤が市場を独占しており、予測期間中もその優位性を維持する可能性が高いです。

Based on indication type segmentation, the atopic contact dermatitis segment is expected to hold the largest market share during the forecast period

地域別では、北米が2023年の売上高でトップ

ヒドロキシジン市場-セグメンテーション分析

市場セグメンテーション

市場は剤形に基づいて、カプセル、錠剤、注射剤、シロップの 4 つのカテゴリに分類されます。 タブレットセグメントは市場を支配しており、予測期間中もその優位性を維持する可能性があります。 ヒドロキシジンなどの抗ヒスタミン薬は消化器系から速やかに吸収され、経口投与後 15 ～ 30 分で臨床効果が現れ始めます。 これらは、精神・神経疾患によってもたらされるストレスや不安を軽減することを目的としています。手術前の睡眠を促進します。このカテゴリーは、アレルギー性疾患や不安症の治療に錠剤の剤形が使用されるようになったことや、神経疾患の有病率の増加により拡大しています。

国際湿疹協議会（International Eczema Council 2022）によると、アトピー性皮膚炎は非常に蔓延しており、成人の最大10％、小児の最大20％が影響を受けています。さらに、その疾病負担は、障害調整生存年数で評価される皮膚疾患では世界第1位、非致死的疾患では世界第15位となっています。

ヒドロキシジン市場-地理的洞察

ヒドロキシジン市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開している国によってさらに分けられます。北米は、アトピー性接触皮膚炎の頻度が高いこと、確立されたインフラが利用可能であること、不安や神経障害の治療に対する意識が高まっていること、受託研究機関と製薬企業との協力関係が増加していることなどから、2023年には最大の市場シェアを占めると予想され、予測期間中も同じパターンが続くとみられています。CDCによると、メンタルヘルスケアを受けている人の割合は、2019年から2021年の間に、全年齢の成人で19.2％から21.6％に、18歳から44歳の個人では18.5％から23.2％に上昇しました。さらに、18歳から44歳の人々の間では、男性よりも女性の方がメンタルヘルスケアを受ける可能性が高かったです。

ヒドロキシジン市場-競合情勢：

市場に参入している主要企業は、Alliance Pharma PLC、OAK PHARMS INC.、Teva Pharmaceutical Industries、Piramal Healthcare UK Limited、Pfizer Inc.、Shanghai Ruizheng Chemical Technology Co.Ltd.、Lupin Pharmaceuticals, Inc.、GlaxoSmithKline plc、Changzhou ComWin Fine Chemicals Co.Ltd.、Impax Laboratories, Inc.、Novartis International AGです。これらの企業は、市場競争力を維持するために、製品の発売、買収、事業拡大、承認、契約など、さまざまなタイプの戦略を採用しています。

目次

第1章 ヒドロキシジン市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ヒドロキシジンの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 ヒドロキシジン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ヒドロキシジン市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 ヒドロキシジン市場情勢

  • ヒドロキシジン市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ヒドロキシジン市場- 剤形別

  • 概要
    • 剤形別セグメントシェア分析
    • カプセル
    • タブレット
    • 注射
    • シロップ

第8章 ヒドロキシジン市場- 適応症の種類別

  • 概要
    • 適応症別セグメントシェア分析
    • 蕁麻疹
    • ヒスタミン媒介性そう痒症
    • アトピー性接触皮膚炎

第9章 ヒドロキシジン市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- ヒドロキシジン業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Alliance Pharma PLC
    • OAK PHARMS INC.
    • Teva Pharmaceutical Industries
    • Piramal Healthcare UK Limited
    • Pfizer Inc.
    • Shanghai Ruizheng Chemical Technology Co., Ltd
    • Lupin Pharmaceuticals, Inc.
    • GlaxoSmithKline plc
    • Changzhou ComWin Fine Chemicals Co., Ltd
    • Impax Laboratories, Inc.
    • Novartis International AG

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hydroxyzine Market: Dosage Form Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Dosage Form
  • TABLE Global Hydroxyzine Market, by Dosage Form 2019-2032 (USD Million)
  • TABLE Hydroxyzine Market: Indication Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication Type
  • TABLE Global Hydroxyzine Market, by Indication Type 2019-2032 (USD Million)
  • TABLE Hydroxyzine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hydroxyzine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE North America Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Europe Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Europe Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Latin America Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Latin America Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
目次
Product Code: ANV2234

REPORT HIGHLIGHT

Hydroxyzine Market size was valued at USD 213.30 Million in 2023, expanding at a CAGR of 5.5% from 2024 to 2032.

Hydroxyzine is an N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy) ethyl and (4-chlorophenyl) (phenyl)methyl groups respectively. It has a role as a H1-receptor antagonist, an anxiolytic drug, a dermatologic drug, an antipruritic drug and an anticoronaviral agent. It is an N-alkylpiperazine, a hydroxyether and a member of monochlorobenzenes.

Hydroxyzine Market- Market Dynamics

The rising prevalence of allergies drives market growth

Over the past several decades, there has been an increase in the frequency of allergies and associated disorders worldwide. The number of people experiencing allergic reactions is increasing for several reasons. As an illustration, Allergy Facts and Figures, which was last updated in April 2022, states that allergies account for the sixth most common cause of chronic disease in the United States, affecting almost 50 million individuals annually. As a result, the nation has a high prevalence of allergies, necessitating improved treatment alternatives. In this regard, a paper published in November 2021 in IJERPH states that, even though the exact causes of allergies are unclear, hereditary and environmental factors contribute significantly to the global burden of allergic illnesses. Furthermore, hydroxyzine may be utilized to relieve allergy-related itching, according to several studies. It is an antihistamine that functions by preventing the body from producing particular organic compounds known as histamine when an allergic response occurs. Thus, there is a growing need for hydroxyzine to control the burden of illness. As a result, the target population's significant allergy load and hydroxyzine therapeutic advantages for allergies are anticipated to drive market expansion.

Hydroxyzine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2024-2032)

Based on dosage form segmentation, the tablets segment dominates the market and is likely to maintain its dominance during the forecast period

Based on indication type segmentation, the atopic contact dermatitis segment is expected to hold the largest market share during the forecast period

Based on region, North America was the leading revenue generator in 2023

Hydroxyzine Market- Segmentation Analysis:

The Global Hydroxyzine Market is segmented based on Dosage form, Indication type and Region.

The market is divided into four categories based on dosage form: capsules, tablets, injections, and syrup. The tablet segment dominates the market and is likely to maintain its dominance during the forecast period. Antihistamine medications such as hydroxyzine are quickly absorbed from the digestive system and start to show clinical effects 15 to 30 minutes after oral administration. These are intended to reduce stress and anxiety brought on by mental and neurological disorders. It facilitates sleep before surgery. The category is growing due to the increasing use of tablet dosage forms for the treatment of allergic illnesses and anxiety, as well as an increase in the prevalence of neurological disorders.

The market is divided into three categories based on indication type: urticaria, histamine-mediated pruritus and atopic contact dermatitis. The atopic contact dermatitis segment is expected to hold the largest market share during the forecast period. The market's revenue has increased as a result of the growing demand for hydroxyzine dosage forms and the increasing prevalence of atopic dermatitis. As per the International Eczema Council 2022, atopic dermatitis is highly prevalent, impacting up to 10% of adults and 20% of children. Furthermore, the illness burden is ranked first for skin conditions evaluated in disability-adjusted life years and 15th globally for nonfatal disorders.

Hydroxyzine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold a maximum market share in 2023 and is expected to continue the same pattern during the forecast period due to the high frequency of atopic contact dermatitis, the availability of well-established infrastructure, the rising awareness of anxiety and nervous disorder therapies, and the rise in collaborations between contract research organizations and pharmaceutical corporations. According to the CDC, the proportion of people receiving mental health care went up from 19.2% to 21.6% for adults of all ages and from 18.5% to 23.2% for individuals between the ages of 18 and 44 between 2019 and 2021. Furthermore, women were more likely than males to undergo mental health care among people aged 18 to 44.

Hydroxyzine Market- Competitive Landscape:

The key players operating in the market are Alliance Pharma PLC, OAK PHARMS INC., Teva Pharmaceutical Industries, Piramal Healthcare UK Limited, Pfizer Inc., Shanghai Ruizheng Chemical Technology Co., Ltd, Lupin Pharmaceuticals, Inc., GlaxoSmithKline plc, Changzhou ComWin Fine Chemicals Co., Ltd, Impax Laboratories, Inc. and Novartis International AG. These players adopted various types of strategies to remain competitive in the market such as product launches, acquisitions, expansion, approvals, agreements and others.

Recent Developments:

In December 2022, the HPRA approved Brillpharma (Ireland) to commercialize Hydroxyzine hydrochloride 25 mg film-coated tablets. These have adult anxiety management licenses.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HYDROXYZINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Alliance Pharma PLC

OAK PHARMS INC.

Teva Pharmaceutical Industries

Piramal Healthcare UK Limited

Pfizer Inc.

Shanghai Ruizheng Chemical Technology Co., Ltd

Lupin Pharmaceuticals, Inc.

GlaxoSmithKline plc

Changzhou ComWin Fine Chemicals Co., Ltd

Impax Laboratories, Inc.

Novartis International AG

GLOBAL HYDROXYZINE MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Capsules
  • Tablets
  • Injections
  • Syrup

GLOBAL HYDROXYZINE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Urticaria
  • Histamine-Mediated Pruritus
  • Atopic Contact Dermatitis

GLOBAL HYDROXYZINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hydroxyzine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hydroxyzine Market Snippet by Dosage Form
    • 2.1.2. Hydroxyzine Market Snippet by Indication Type
    • 2.1.3. Hydroxyzine Market Snippet by Country
    • 2.1.4. Hydroxyzine Market Snippet by Region
  • 2.2. Competitive Insights

3. Hydroxyzine Key Market Trends

  • 3.1. Hydroxyzine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hydroxyzine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hydroxyzine Market Opportunities
  • 3.4. Hydroxyzine Market Future Trends

4. Hydroxyzine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hydroxyzine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hydroxyzine Market Landscape

  • 6.1. Hydroxyzine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hydroxyzine Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 7.1.2. Capsules
    • 7.1.3. Tablets
    • 7.1.4. Injections
    • 7.1.5. Syrup

8. Hydroxyzine Market - By Indication Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
    • 8.1.2. Urticaria
    • 8.1.3. Histamine-Mediated Pruritus
    • 8.1.4. Atopic Contact Dermatitis

9. Hydroxyzine Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Hydroxyzine Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Hydroxyzine Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Hydroxyzine Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Hydroxyzine Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Hydroxyzine Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hydroxyzine Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Alliance Pharma PLC
    • 10.2.2. OAK PHARMS INC.
    • 10.2.3. Teva Pharmaceutical Industries
    • 10.2.4. Piramal Healthcare UK Limited
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Shanghai Ruizheng Chemical Technology Co., Ltd
    • 10.2.7. Lupin Pharmaceuticals, Inc.
    • 10.2.8. GlaxoSmithKline plc
    • 10.2.9. Changzhou ComWin Fine Chemicals Co., Ltd
    • 10.2.10. Impax Laboratories, Inc.
    • 10.2.11. Novartis International AG

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us